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Abstract
46 year old patient was admitted as an emergency with vomiting, hypotension and serum cortisol
of 0,940 μg/dl (26 nmol/l) indicative of adrenal failure. Despite previous history of
panhypopituitarism he was found to be hyperthyroid [free T4 6.32 ng/dl (ref. range: 0.93–1.7), free
T3 22.21 pg/ml (ref. range: 1.8–4.6)]. He was fit and well till the age of 45. Eight months prior to this
hospitalisation he presented with diabetes insipidus and was found to have a large cystic tumour in
the area of the pituitary gland. Surgery was only partially successful and histologically the tumour
was diagnosed as craniopharyngioma. Endocrine assessment revealed deficiency in ACTH-cortisol,
growth hormone, and gonadotropin, as well as low-normal free T4. On the day of his emergency
admission he looked ill and dehydrated, though was fully conscious and cooperative. Heart rate was
120 beats/min (sinus rhythm), blood pressure 85/40 mm Hg. There were no obvious features of
infection, but there was marked tremor and thyroid bruit. He received treatment with intravenous
fluids and hydrocortisone. L-thyroxine was stopped. Administration of large dose of methimazole
(60 mg/day) resulted in gradual decrease in free T4 and free T3 (to 1.76 ng/ml, and 5.92 pg/ml,
respectively) over a 15-day period. The patient was found to have increased titre of
antithyroperoxidase (anti-TPO) and anti-TSH receptor (anti-TSHR) antibodies [2300 IU/l (ref.
range <40) and 3.6 IU/l (ref. range <1.0), respectively]. He was referred for radioactive iodine
treatment. Iodine uptake scan performed prior to radioiodine administration confirmed uniformly
increased iodine uptake consistent with Graves' disease.
Conclusion:  Our case illustrates coexistence of hypopituitarism and clinically significant
autoimmune thyroid disease. The presence of hypopituitarism does not preclude the development
of autoimmune thyrotoxicosis.
Background
Adrenal insufficiency of either a primary or secondary ori-
gin may culminate in a life-threatening adrenal crisis [1].
Acute stress situations or other co-existent disease can
aggravate symptomatology of glucocorticoid deficiency.
Such conditions usually include acute infections or cardi-
ovascular events. It is, however, also well recognized that
thyroid hormones accelerate glucocorticoid turnover, so
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that thyrotoxicosis may increase glucocorticoid require-
ments in subjects on hydrocortisone replacement [2]. We
present a case where a subject with known panhypopitui-
tarism, including incipient secondary hypothyroidism,
developed florid thyrotoxicosis that, in turn, contributed
to an acute glucocorticoid deficiency.
Case presentation
Acute presentation
A 46 year old patient was admitted as an emergency with
vomiting, hypotension and serum cortisol of 0.940 μg/dl
(26 nmol/l) indicative of an adrenal failure. Despite pre-
vious history of panhypopituitarism he was found to be
hyperthyroid [free T4 6.32 ng/dl (ref. range: 0.93–1.7),
free T3 22.21 pg/ml (ref. range: 1.8–4.6)], see Table 1.
Past Medical History
He was fit and well till the age of 45. His height was 183
cm, BMI 25.5 kg/m2. The was no family history of autoim-
mune disease. Eight months prior to this hospitalisation
he presented with diabetes insipidus and was found to
have a large cystic tumour in the area of the pituitary gland
(presented in Figure 1). There was also evidence of hypo-
pituitarism with evident hypogonadotropic hypogonad-
ism, accompanied by relatively low 8 am cortisol, as well
as low TSH and free T4 and free T3 at the lower limit of the
reference range, i.e., a feature indicative of an incipient
secondary hypothyroidism (Table 1). The patient was sub-
sequently referred for transcranial surgery. Complete
removal of the mass was not feasible, and so only a
debulking procedure was performed. Endocrine assess-
ment completed after his discharge from neurosurgical
department revealed deficiency in ACTH-cortisol and
gonadotropin axes, as well as low-normal free T4 (Table
1). Subsequently he was also found to have low IGF-I
indicative of growth hormone deficiency. He was com-
menced on hydrocortisone (20 mg in the morning+10 mg
at noon), oral desmopressin (0.2 mg tds), fortnightly
intramuscular testosterone and L-thyroxine (25 μg od).
His clinical condition remained stable for about five
months, i.e., till about 4 weeks prior to the emergency
hospitalisation. At that time he developed palpitations,
and lost about 4 kg of weight. Over this period his condi-
tion gradually deteriorated, with increased ill-being and
eventual vomiting.
On the day of his emergency admission he looked ill and
dehydrated, though was fully conscious and cooperative.
Heart rate was 120 beats/min (sinus rhythm), blood pres-
sure 85/40 mm Hg. There were no obvious features of
infection, but he was found to have marked tremor and
thyroid bruit. Mild lid-lag sign was present, however,
without any obvious orbitopathy. He was found to have
very low cortisol, with markedly raised free T4 and free T3,
Table 1: Biochemical and hormonal results of patient at the time of diagnosis, after debulking of craniopharyngioma and on the day of 
emergency admission.
Before surgery After surgery (one month later) On admission with adrenal crisis 
(Five months later)
Reference range
Sodium [mmol/l] 144 139 141 135–150
Potassium [mmol/l] 3.9 4.3 3.9 3.5–5.0
Creatinine [mg/dl] 0.8 0.8 0.9 0.6–1.4
TSH [mU/l] 0.069 0.007 0.010 0.27–4.2
Free T4 [ng/dl] 0.952 1.32 6.32 0.93–1.7
Free T3 [pg/ml ] 1.87 1.52 22.21 1.8–4.6
LH [IU/l] 0.588 <0.100 not assessed 1.7–8.6
FSH [IU/l] 0.530 0.135 not assessed 1.5–12.4
Testosterone [ng/ml] 0.355 0.023 not assessed 2.8 – 8.0
8 am Cortisol [μg/dl] 7.79* 0.168** 0.940 6.2–19.4
Prolactin [ng/ml] 18.56 16.1 not assessed 3.4–24.1
*Without hydrocortisone replacement. In order to covert μg/dl to nmol/l multiply by 27.6
**Hydrocortisone omitted in the afternoon prior to measurement.Thyroid Research 2008, 1:7 http://www.thyroidresearchjournal.com/content/1/1/7
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as presented in Table 1. His full blood count revealed hae-
moglobin of 14.1 g/dl, white cell count of 5.27 × 103/μl,
with normal differential and serum osmolality 281 mOs-
mol/kg H2O. His remaining biochemical results on the
day of his acute admission are also presented in Table 1.
Treatment and Progress
He received treatment with intravenous fluids and hydro-
cortisone initially 100 mg intravenously every 8 hours for
the first 24 hours. L-thyroxine was stopped. Administra-
tion of large dose of oral methimazole (60 mg/day)
resulted in gradual decrease in free T4 and free T3 (to 1.76
ng/ml, and 5.92 pg/ml, respectively) over a 15-day period,
as presented in Table 2. He was found to have increased
titre of antithyroperoxidase (anti-TPO) and anti-TSH
receptor (anti-TSHR) antibodies [2300 IU/l (ref. range
<40) and 3.6 IU/l (ref. range <1.0), respectively]. Both thy-
roid hormones and anti-TPO and anti-TSHR antibodies
were measured by standard commercial assay kits pro-
vided by Roche Diagnostics, Indianapolis, USA. He was
subsequently referred for treatment with radioactive
iodine. Iodine uptake scan, performed prior to radioiod-
ine administration, confirmed uniformly increased iodine
uptake consistent with Graves' disease (Figure 2). Two
months after administration of radioactive iodine, he
required further debulking of craniopharyngioma. At that
point he was found to have low free T4 [0.84 ng/dl (ref.
range: 0.93–1.7)], and free T3 [1.0 pg/ml (ref. range: 1.8–
4.6)], indicative of radioiodine-induced hypothyroidism.
He was recommenced on L-thyroxine, the dose of which
was gradually increased to 100 μg daily. Since then his
condition remains stable.
Discussion
Our case illustrates development of autoimmune thyro-
toxicosis in the setting of known previous panhypopitut-
arism. From clinical viewpoint, the most important factor
is to recognise that such combination of two opposite
conditions, i.e., thyrotoxicosis despite previous secondary
hypothyroidism is indeed possible. Coexistence of hypo-
pitutarism and thyrotoxicosis, though rare, has been
described in literature. Some of these patients, however,
developed serious complications, like thyrotoxic coma
[3], or radioiodine-induced thyroid storm [4]. In the latter
case Graves' disease developed eight years after the docu-
mentation of hypopituitarism in a patient also diagnosed
with a craniopharyngioma. More recently a possibility of
coexistence of TSH-secreting pituitary adenomas and
autoimmune hypothyroidism [5], a coexistence of Graves'
disease and macroprolactinoma [6] or Graves' disease and
lymphocytic hypophysitis [7] have been described.
There is also evidence of significantly raised prevalence of
thyroid disorders in patients with acromegaly, regardless
of the preservation of other hormonal axes [8,9]. This
includes a large Polish series of about 360 patients with
T1-weighted magnetic resonance images of cystic tumour of the described patient Figure 1
T1-weighted magnetic resonance images of cystic tumour of the described patient. Subsequently this was found to 
represent craniopharyngioma.Thyroid Research 2008, 1:7 http://www.thyroidresearchjournal.com/content/1/1/7
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acromegaly, where the presence of goitre was observed in
59.2% of cases, while overt hyperthyroidism developed in
8.6% of patients [8].
The patient described above had coexistent nanhypopitu-
itarism and clinically significant autoimmune thyroid dis-
ease. Thyroid hormones are known to increase the
turnover of cortisol. Our patient developed marked thyro-
toxicosis during the course of Graves' disease, but failed to
increase his hydrocortisone replacement. The combina-
tion of thyrotoxicosis in the setting of increased cortisol
requirements had lead to a vicious circle resulting in life-
threatening adrenal crisis.
Iodide uptake scan of the described patient prior to radioiodine administration Figure 2
Iodide uptake scan of the described patient prior to radioiodine administration. Uniformly increased uptake plus 
raised titre of anti-TPO and anti-TSHR antibodies were indicative of Graves' disease as the cause of thyrotoxicosis.Publish with BioMed Central    and   every 
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Conclusion
In summary, we have demonstrated that even severe
hypopituitarism does not preclude the development of
autoimmune thyrotoxicosis. These conditions are there-
fore not mutually exclusive and may indeed coexist in the
same patient. Our case, therefore, highlights the need for
awareness of possible coexistence of these conditions
among endocrinologists, neurosurgeons and general phy-
sicians.
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